Use of cytohesin-PH peptides to influence the adhesion capability of integrins

The following are new: (1) The cytohesin-2 peptide (A) with the 263 amino acid sequence (given in the specification); and (2) The use of a cytohesin PH peptide (B) for regulation of T-lymphocyte activation. Also claimed are: (3) DNA coding for at least part of (A); (4) use of (B)-encoding DNA for ex...

Full description

Saved in:
Bibliographic Details
Main Authors KOLANUS, WALDEMAR, OSTNER, BRITTA, DB
Format Patent
LanguageEnglish
French
German
Published 19.06.2002
Edition7
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The following are new: (1) The cytohesin-2 peptide (A) with the 263 amino acid sequence (given in the specification); and (2) The use of a cytohesin PH peptide (B) for regulation of T-lymphocyte activation. Also claimed are: (3) DNA coding for at least part of (A); (4) use of (B)-encoding DNA for expression of (B); (5) use of a vector contg. the DNA of (4) for expression of (B); and (6) use of a host cell contg. the vector of (5).
Bibliography:Application Number: EP19960114413